Search Page

1

Cite

Share

Clinical pharmacokinetics of metformin.

Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Graham GG, et al. Among authors: day ro. Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21241070 Review.

Cite

Share

2

Cite

Share

Effects of Allopurinol on the Progression of Chronic Kidney Disease.

Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW; CKD-FIX Study Investigators. Badve SV, et al. Among authors: day ro. N Engl J Med. 2020 Jun 25;382(26):2504-2513. doi: 10.1056/NEJMoa1915833. N Engl J Med. 2020. PMID: 32579811 Clinical Trial.

Cite

Share

3

Cite

Share

Allopurinol hypersensitivity: investigating the cause and minimizing the risk.

Stamp LK, Day RO, Yun J. Stamp LK, et al. Among authors: day ro. Nat Rev Rheumatol. 2016 Apr;12(4):235-42. doi: 10.1038/nrrheum.2015.132. Epub 2015 Sep 29. Nat Rev Rheumatol. 2016. PMID: 26416594 Review.

Cite

Share

4

Cite

Share

Trial of Pregabalin for Acute and Chronic Sciatica.

Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin CC. Mathieson S, et al. Among authors: day ro. N Engl J Med. 2017 Mar 23;376(12):1111-1120. doi: 10.1056/NEJMoa1614292. N Engl J Med. 2017. PMID: 28328324 Free article. Clinical Trial.

Cite

Share

5

Cite

Share

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.

Milder TY, Stocker SL, Day RO, Greenfield JR. Milder TY, et al. Among authors: day ro. Drug Saf. 2020 Dec;43(12):1211-1221. doi: 10.1007/s40264-020-01010-6. Epub 2020 Oct 23. Drug Saf. 2020. PMID: 33095409 Free PMC article. Review.

Cite

Share

6

Cite

Share

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. Graham GG, et al. Among authors: day ro. Inflammopharmacology. 2013 Jun;21(3):201-32. doi: 10.1007/s10787-013-0172-x. Epub 2013 May 30. Inflammopharmacology. 2013. PMID: 23719833 Review.

Cite

Share

7

Cite

Share

Bioavailability of hydroxychloroquine tablets in healthy volunteers.

Tett SE, Cutler DJ, Day RO, Brown KF. Tett SE, et al. Among authors: day ro. Br J Clin Pharmacol. 1989 Jun;27(6):771-9. doi: 10.1111/j.1365-2125.1989.tb03439.x. Br J Clin Pharmacol. 1989. PMID: 2757893 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.

Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CW, Day RO, McLachlan AJ, Ferreira ML. Machado GC, et al. Among authors: day ro. BMJ. 2015 Mar 31;350:h1225. doi: 10.1136/bmj.h1225. BMJ. 2015. PMID: 25828856 Free PMC article. Review.

Cite

Share

9

Cite

Share

Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

Broeker A, Nardecchia M, Klinker KP, Derendorf H, Day RO, Marriott DJ, Carland JE, Stocker SL, Wicha SG. Broeker A, et al. Among authors: day ro. Clin Microbiol Infect. 2019 Oct;25(10):1286.e1-1286.e7. doi: 10.1016/j.cmi.2019.02.029. Epub 2019 Mar 11. Clin Microbiol Infect. 2019. PMID: 30872102 Free article.

Cite

Share

10

Cite

Share

Predictors of Success in Gout Treatment.

Day RO, Coleshill MJ, Stocker SL, Nguyen AD, Robinson P, Aung E. Day RO, et al. J Rheumatol. 2020 Mar;47(3):313-315. doi: 10.3899/jrheum.191150. J Rheumatol. 2020. PMID: 32115433 No abstract available.

Cite

Share